Please login to the form below

Not currently logged in
Email:
Password:

teriflunomide

This page shows the latest teriflunomide news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s oral therapy Aubagio approved in the EU for paediatric MS patients

Sanofi’s oral therapy Aubagio approved in the EU for paediatric MS patients

The EC has cleared Aubagio (teriflunomide) as a first-line treatment for paediatric RRMS patients who are ten to 17 years old.

Latest news

More from news
Approximately 6 fully matching, plus 56 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...